Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
05/2007
05/31/2007WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007WO2007060408A2 L-phenylalanine derivatives and their use as integrin antagonists
05/31/2007WO2007059613A1 Antineoplastic compounds
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/31/2007WO2006113552A3 Cyanoarylamines
05/31/2007WO2006058700A8 Acetamide compounds as fungicides
05/31/2007US20070123734 economical; nontoxic; high yield; industrial scale; Grignard reaction; iron catalyst (FeCl3) and a diamine (ethylenediamine); cross-coupling of alkyl halide and aromatic organometallic; primary or secondary alkyl substituents; phenylcycloheptane from bromocycloheptane and phenyl magnesium bromide
05/31/2007US20070123710 Industrial method for seperation and purification of fentanyl by reverse phase preparative chromatography
05/31/2007US20070123709 Beta-amino acids
05/31/2007US20070123706 Method for producing 3-amidinophenylalanine derivatives
05/31/2007US20070123565 Donepezil Hydrochloride Form VI
05/31/2007US20070123564 Method for preparing phenyl acetic acid derivatives
05/31/2007US20070123546 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases
05/31/2007US20070123509 Carboxamide derivatives
05/31/2007US20070123508 PAR2-modulating compounds and their use
05/31/2007CA2630465A1 Antineoplastic compounds
05/31/2007CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007CA2630324A1 Process for synthesizing remifentanil
05/31/2007CA2630254A1 New pleuromutilin derivative and its use
05/30/2007EP1790640A1 Novel imidazolidine derivative and use thereof
05/30/2007EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
05/30/2007EP1790636A1 Piperidine derivatives and use thereof
05/30/2007EP1789410A1 Methylene dipiperidine derivatives
05/30/2007EP1789389A1 Piperidine compound and process for preparing the same
05/30/2007EP1789388A2 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
05/30/2007EP1789377A1 Alternative synthesis of renin inhibitors and intermediates thereof
05/30/2007EP1613591B1 Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof
05/30/2007EP1285655B1 Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1972920A Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms
05/30/2007CN1972912A Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives
05/30/2007CN1972909A Thio-substituted arylmethanesulfinyl derivatives
05/30/2007CN1318393C Process for the preparation of 4-haloalkylnicotinonitriles
05/29/2007USRE39667 3,3-Diphenylpropylamines, their use and preparation
05/29/2007US7223867 Preparation of benzosuberonylpiperidine compounds
05/29/2007US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders
05/29/2007US7223779 Azasugar derivative and drug containing the same as the active ingredient
05/29/2007US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity
05/29/2007US7223759 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains
05/24/2007WO2007058960A1 Sulfamoyl benzamides as cannabinoid receptor modulators
05/24/2007WO2007058305A1 Process for production of cinnamamide derivative
05/24/2007WO2007057643A1 Process for preparing beta- (fluorophenyl) -propanoate ester derivatives
05/24/2007WO2007057226A2 Process for making donepezil
05/24/2007WO2007028073A3 Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
05/24/2007WO2006042150A8 Diaminoalkane aspartic protease inhibitors
05/24/2007US20070117847 N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists
05/24/2007US20070117846 Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine and hydrochloride thereof
05/24/2007DE4327297B4 Verwendung von Piperidinverbindungen Using piperidine
05/24/2007CA2628047A1 Process for production of cinnamide derivative
05/24/2007CA2627552A1 Process for preparing beta- (fluorophenyl) -propanoate ester derivatives
05/23/2007EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases
05/23/2007EP1786809A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
05/23/2007EP1786775A1 Dimeric piperidine derivates
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007CN1968926A Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine and hydrochloride thereof
05/23/2007CN1317276C Indolylpiperidine compound and preparation process and use thereof
05/22/2007US7220884 Hydroaminomethylation of olefins
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220876 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals
05/22/2007US7220869 To be used as acidic catalysts
05/22/2007US7220863 Reducing with hydrogen using 3-substituted-2,5,6-trifluoropyridine as a starting material for preparing 2-aminopyridine derivatives
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007CA2276694C New fatty acid derivatives
05/22/2007CA2275353C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
05/22/2007CA2212200C Novel inhibitors of .beta.-glucuronidase
05/22/2007CA2157146C Heterocyclyl-benzoylguanidines
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007055197A1 Method for producing 4-(3-(4-(3-(4-cyanophenoxy)propyl)- 1-piperidinyl)propoxy)benzonitrile and intermediate thereof
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007012953A3 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
05/18/2007WO2006041635A8 Arylthiobenzylpiperidine derivatives
05/17/2007US20070112200 Non-racemic hexafluoreleucine,and methods of making and using it
05/17/2007US20070112030 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
05/17/2007US20070112029 Piperidine compound and process for preparing the same
05/17/2007US20070112028 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
05/17/2007US20070112022 Piperidine derivatives as ccr5 receptor modulators
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070112000 Chemical compounds
05/17/2007US20070111971 Novel compounds
05/16/2007EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/16/2007EP1784401A1 Urea derivatives as calcium channel blockers
05/16/2007EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
05/16/2007CN1964965A Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
05/16/2007CN1964964A Piperidine derivates for the treatment of chemokines mediared disease
05/16/2007CN1962655A Method for extracting nicotine from waste tobacco leaf through liquid film method
05/16/2007CN1315821C Improvement of preparation of N-methyl-3- (1-methyl-4-piperidine)-1,4-indole-5-ethyl thiamine
05/15/2007US7217823 4,4-Disubstituted piperidines, and methods of use thereof
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/15/2007US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/15/2007US7217702 Adenine derivatives, especially substituted with an alkynylene-, alkenylene-, alkadienylene- or alkynylenealkenylene- group; e.g., 2-{3-[1-(Methoxycarbanoyl)piperidin-4-yl]propyn-1-yl}-9-propargyladenine; stimulating motor activity without dyskinesia; treating Huntington's & Parkinson's diseases, etc.
05/15/2007CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
05/15/2007CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds
05/15/2007CA2116167C One-component coating compositions containing oxime- or lactam-blocked polyisocyanates which have improved resistance to yellowing
05/10/2007WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
05/10/2007WO2007053427A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
05/10/2007WO2007053145A1 Haloperidol analogs